Loading
Latest filing published 24 Dec 2008 for PHARMACOPEIA DRUG DISCOVERY INC.
No signal scores available.
Stephen C. Costalas discloses dealings in Pharmacopeia Drug Discovery Inc to SEC (Form 4). Between 30 December 2005 and 23 December 2008, the trades on record add up to 35 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 24 December 2008 came the latest disclosure, a transaction in Pharmacopeia Drug Discovery Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 34 declarations